Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

48.88 -0.45 (-0.91%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 870,343
Open 48.78
Bid (Size) 40.00 (300)
Ask (Size) 50.70 (100)
Prev. Close 49.33
Today's Range 48.53 - 49.79
52wk Range 23.23 - 49.92
Shares Outstanding 32,250,236
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Unpopular Stocks We Find Risky
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Fits the Minervini Growth Momentum Strategy ↗
Collegium Pharmaceutical (COLL) aligns with Mark Minervini's SEPA strategy, showing a strong technical uptrend and robust fundamental earnings and sales growth. 
Via Chartmill

Performance

YTD
+70.7%
+70.7%
1 Month
+9.9%
+9.9%
3 Month
+36.7%
+36.7%
6 Month
+63.9%
+63.9%
1 Year
+60.2%
+60.2%

More News

Read More
News headline image
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
1 Growth Stock Set to Flourishand 2 Facing Challenges
Via StockStory
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
1 Mooning Stock with Promising Prospects and 2 Facing Challenges
Via StockStory
News headline image
1 Small-Cap Stock with Exciting Potential and 2 We Avoid
Via StockStory
News headline image
Branded Pharmaceuticals Stocks Q3 Earnings: Eli Lilly (NYSE:LLY) Best of the Bunch
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows High Growth Momentum with Strong Technicals ↗
Via Chartmill
News headline image
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call
Via StockStory
Topics Earnings
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off
Via StockStory
News headline image
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
2 Momentum Stocks with Exciting Potential and 1 We Find Risky
Via StockStory
Topics Credit Cards
News headline image
COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook
Via StockStory
News headline image
Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today
Via StockStory
Topics Economy Government World Trade
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Beats Q3 2025 Estimates and Raises Full-Year Guidance ↗
Via Chartmill
News headline image
Collegium Pharmaceutical (NASDAQ:COLL) Delivers Impressive Q3, Stock Jumps 12.1%
Via StockStory
News headline image
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Earnings To Watch: Collegium Pharmaceutical (COLL) Reports Q3 Results Tomorrow
Via StockStory
News headline image
3 Stocks Under $50 That Fall Short
Via StockStory
Topics Artificial Intelligence
News headline image
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Pharmaceutical (COLL): Buy, Sell, or Hold Post Q2 Earnings?
Via StockStory
Topics Stocks Supply Chain
News headline image
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
The current price of Collegium Pharmaceutical, Inc. - Common Stock is 48.88
When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 12/19/25 04:00 PM ET
What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.58B
How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
Collegium Pharmaceutical, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.